Literature DB >> 10620075

Down-regulation of the serum stimulatory components of the insulin-like growth factor (IGF) system (IGF-I, IGF-II, IGF binding protein [BP]-3, and IGFBP-5) in age-related (type II) femoral neck osteoporosis.

S Boonen1, S Mohan, J Dequeker, J Aerssens, D Vanderschueren, G Verbeke, P Broos, R Bouillon, D J Baylink.   

Abstract

Both a decrease in bone formation and an increase in bone resorption have been implicated in the pathogenesis of age-related (type II) femoral neck osteoporosis. While the increase in the bone resorption rate has been shown to be partially related to secondary hyperparathyroidism, the mechanisms underlying the decline in bone formation have not yet been identified. The aim of the present study was to test the hypothesis that the bone formation deficit associated with type II osteoporosis might be due to secondary hyperparathyroidism and/or to a deficiency of the insulin-like growth factor (IGF) system. Circulating concentrations of IGF-I, IGF-II, IGF binding protein (IGFBP)-3, IGFBP-4, IGFBP-5, 25-hydroxycholecalciferol (25(OH)D3), and intact parathyroid hormone (PTH) were measured in 50 elderly women after sustaining a hip fracture and in 50 healthy age-matched controls. In addition, serum levels of osteocalcin (OC), skeletal alkaline phosphatase, and N-terminal procollagen peptide and urinary pyridinium cross-links were determined as markers of bone remodeling, and bone mineral density (BMD) was assessed at the proximal femur. In the patient group, serum was drawn within 18 h of the fracture and prior to surgery. Circulating protein concentrations did not change over this time frame. No difference was found between mean IGFBP-4 serum levels in the two groups studied, while mean levels of IGF-I, IGF-II, IGFBP-3, IGFBP-5, 25(OH)D3, and markers of bone formation were significantly lower (p < 0.006) in patients as compared with healthy subjects. Serum PTH and urinary pyridinium cross-links, however, were markedly increased (p < 0.001) in the osteoporotic group. In pooled data from the normal and osteoporotic populations, age-adjusted multiple regression models based on IGF-I, IGF-II, IGFBP-3, and IGFBP-5 were found to be highly predictive of serum OC (R2 = 19%, p < 0.001) and BMD of femoral neck (R2 = 49%, p < 0.0001), consistent with an effect of the anabolic IGF components on overall bone formation rate. Similar models based on 25(OH)D3 and PTH, however, were statistically unrelated to OC. To address further the potential impact of trauma on circulating IGF system components, we measured IGF system component levels in 10 male patients within 18 h following tibial fracture and in 10 age-matched normal male subjects. There was no significant difference in serum level of any of the IGF system components between the two groups. Although limited by its cross-sectional design, the present study suggests that, in addition to bone resorption resulting from secondary hyperparathyroidism, impaired bone formation associated with deficiency of the IGF system might predispose elderly women to fragility fracture of the proximal femur.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10620075     DOI: 10.1359/jbmr.1999.14.12.2150

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  36 in total

Review 1.  The multi-functional role of insulin-like growth factor binding proteins in bone.

Authors:  Kristen E Govoni; David J Baylink; Subburaman Mohan
Journal:  Pediatr Nephrol       Date:  2004-11-11       Impact factor: 3.714

2.  Differences in exposure to stimulatory and inhibitory components of the insulin-like growth factor (IGF) system in patients with femoral neck versus trochanteric fracture.

Authors:  S Boonen; D Vanderschueren; K Venken; P Geusens; P Haentjens; S Mohan; D J Baylink; R Bouillon
Journal:  Age Ageing       Date:  2005-03       Impact factor: 10.668

Review 3.  Male osteoporosis.

Authors:  Matthew T Drake; Sundeep Khosla
Journal:  Endocrinol Metab Clin North Am       Date:  2012-06-17       Impact factor: 4.741

4.  Increased In Vitro Osteopotential in SHED Associated with Higher IGF2 Expression When Compared with hASCs.

Authors:  Roberto Dalto Fanganiello; Felipe Augusto Andre Ishiy; Gerson Shigeru Kobayashi; Lucas Alvizi; Daniele Yumi Sunaga; Maria Rita Passos-Bueno
Journal:  Stem Cell Rev Rep       Date:  2015-08       Impact factor: 5.739

5.  Aging and bone loss: new insights for the clinician.

Authors:  Oddom Demontiero; Christopher Vidal; Gustavo Duque
Journal:  Ther Adv Musculoskelet Dis       Date:  2012-04       Impact factor: 5.346

Review 6.  Interaction between bone and muscle in older persons with mobility limitations.

Authors:  L Ferrucci; M Baroni; A Ranchelli; F Lauretani; M Maggio; P Mecocci; C Ruggiero
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

Review 7.  Insulin-like growth factors: actions on the skeleton.

Authors:  Shoshana Yakar; Haim Werner; Clifford J Rosen
Journal:  J Mol Endocrinol       Date:  2018-04-06       Impact factor: 5.098

Review 8.  Osteoporosis in men.

Authors:  Sundeep Khosla; Shreyasee Amin; Eric Orwoll
Journal:  Endocr Rev       Date:  2008-05-01       Impact factor: 19.871

9.  Mapping quantitative trait loci that influence serum insulin-like growth factor binding protein-5 levels in F2 mice (MRL/MpJ X SJL/J).

Authors:  Subburaman Mohan; Godfred Masinde; Xinmin Li; David J Baylink
Journal:  Endocrinology       Date:  2003-08       Impact factor: 4.736

10.  Gender differences in pediatric burn patients: does it make a difference?

Authors:  Marc G Jeschke; Ronald P Mlcak; Celeste C Finnerty; William B Norbury; Rene Przkora; Gabriela A Kulp; Gerd G Gauglitz; Xiao-Jun Zhang; David N Herndon
Journal:  Ann Surg       Date:  2008-07       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.